Three Underappreciated Female Pioneers of Synthetic Biology The field of synthetic biology has come a long way from the CRISPR-less days of the early aughts. In 2000, bioengineers made the leap from studying natural...
Protein engineering
Protalix BioTherapeutics Completes Raise of Approximately $40 Million in Gross Proceeds
Anticipated PDUFA for PRX-102 in Fabry disease currently set for April 27, 2021 Company, with its Commercialization Partner, Chiesi, poised to commercialize PRX-102 Additional data and milestones expected throughout...
